These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23660192)

  • 1. Effects of IV iron isomaltoside-1000 treatment on regional brain iron status in an iron-deficient animal.
    Unger EL; Earley CJ; Thomsen LL; Jones BC; Allen RP
    Neuroscience; 2013 Aug; 246():179-85. PubMed ID: 23660192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.
    Allen RP; Earley CJ; Jones BC; Unger EL
    Sleep Med; 2020 Jul; 71():141-148. PubMed ID: 32094092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
    Birgegård G; Henry D; Glaspy J; Chopra R; Thomsen LL; Auerbach M
    Pharmacotherapy; 2016 Apr; 36(4):402-14. PubMed ID: 26927900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.
    Kalra PA; Bhandari S; Saxena S; Agarwal D; Wirtz G; Kletzmayr J; Thomsen LL; Coyne DW
    Nephrol Dial Transplant; 2016 Apr; 31(4):646-55. PubMed ID: 26250435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low brain iron effects and reversibility on striatal dopamine dynamics.
    Unger EL; Bianco LE; Jones BC; Allen RP; Earley CJ
    Exp Neurol; 2014 Nov; 261():462-8. PubMed ID: 24999026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy.
    Wesström J
    Arch Gynecol Obstet; 2020 May; 301(5):1127-1131. PubMed ID: 32270330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial.
    Gybel-Brask M; Seeberg J; Thomsen LL; Johansson PI
    Transfusion; 2018 Apr; 58(4):974-981. PubMed ID: 29424441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
    Wolf M; Rubin J; Achebe M; Econs MJ; Peacock M; Imel EA; Thomsen LL; Carpenter TO; Weber T; Brandenburg V; Zoller H
    JAMA; 2020 Feb; 323(5):432-443. PubMed ID: 32016310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside.
    Detlie TE; Lindstrøm JC; Jahnsen ME; Finnes E; Zoller H; Moum B; Jahnsen J
    Aliment Pharmacol Ther; 2019 Aug; 50(4):397-406. PubMed ID: 31264261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease.
    Kalra PA; Bhandari S; Spyridon M; Davison R; Lawman S; Mikhail A; Reaich D; Pritchard N; McCafferty K; Moore J
    BMC Nephrol; 2020 Dec; 21(1):539. PubMed ID: 33302891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial.
    Markova V; Hansen R; Thomsen LL; Pinborg A; Moos T; Holm C
    Trials; 2020 Aug; 21(1):742. PubMed ID: 32843079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron (III) isomaltoside 1000.
    Mace TA; Syed A; Bhandari S
    Expert Rev Hematol; 2013 Jun; 6(3):239-46. PubMed ID: 23782077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency.
    Charles-Edwards G; Amaral N; Sleigh A; Ayis S; Catibog N; McDonagh T; Monaghan M; Amin-Youssef G; Kemp GJ; Shah AM; Okonko DO
    Circulation; 2019 May; 139(21):2386-2398. PubMed ID: 30776909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective observational study of effectiveness and safety of iron isomaltoside in patients with chronic renal failure and iron deficiency anemia
.
    Biggar P; Leistikow F; Walper A
    Clin Nephrol; 2016 Dec; 86 (2016)(12):310-318. PubMed ID: 27737531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
    Bhandari S; Kalra PA; Kothari J; Ambühl PM; Christensen JH; Essaian AM; Thomsen LL; Macdougall IC; Coyne DW
    Nephrol Dial Transplant; 2015 Sep; 30(9):1577-89. PubMed ID: 25925701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Resource Impact Model for Clinics Treating Pre-Operative Iron Deficiency Anemia in Ireland.
    Loughnane F; Muduma G; Pollock RF
    Adv Ther; 2020 Mar; 37(3):1218-1232. PubMed ID: 32030608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
    Derman R; Roman E; Modiano MR; Achebe MM; Thomsen LL; Auerbach M
    Am J Hematol; 2017 Mar; 92(3):286-291. PubMed ID: 28052413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment.
    Pollock RF; Muduma G
    Expert Rev Hematol; 2019 Feb; 12(2):129-136. PubMed ID: 30689458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience.
    Jesus-Silva JA; Lamplugh A; Dhada S; Burton JO; Bhandari S
    BMC Nephrol; 2020 Jun; 21(1):212. PubMed ID: 32493240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.
    Pollock RF; Muduma G
    Adv Ther; 2018 Dec; 35(12):2128-2137. PubMed ID: 30456520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.